Vericel Corp (NAS:VCEL)
$ 48.23 0.24 (0.5%) Market Cap: 2.34 Bil Enterprise Value: 2.33 Bil PE Ratio: 9,999.00 PB Ratio: 10.00 GF Score: 82/100

Vericel Corp at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 14, 2021 / 04:40PM GMT
Release Date Price: $38.52 (+4.33%)
Raphael Taubenfeld
JP Morgan Chase & Co. - VP of Healthcare Investment Banking

Hello, everyone. Good morning. My name is Raphael Taubenfeld. I'm a member of the Healthcare Investment Banking team here at JPMorgan. Welcome to the final day of the Virtual JPMorgan Healthcare Conference.

We have the pleasure here with us today to have Nick Colangelo, President and CEO of Vericel here with us. We'll be going through the presentation in a moment. (Operator Instructions)

And with that, I'll hand it over to Nick.

Dominick C. Colangelo
Vericel Corporation - CEO, President & Director

Well, thank you, Raphael. It is great to be here today, and we really appreciate the opportunity to present for the first time at the JPMorgan conference. And before I begin, I'll just remind those in attendance that this presentation contains forward-looking statements, so you should refer to our documents on file with the SEC for further information.

So starting at Slide 3. Vericel is a leader in advanced therapies for the sports medicine and the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot